SPECTRUM AND SEVERITY OF ADVERSE DRUG REACTIONS DURING TREATMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS PATIENTS. Int. Res. J. Pharm. 2026, 17 (9), 11-17. https://doi.org/10.56802/cyzkpf46.